Dharti Proteins Ltd has announced a board meeting on October 13, 2026, to approve its Q2 and H1 FY27 financial results. Most importantly, the board will consider a bonus share proposal aimed at meeting regulatory Minimum Public Shareholding (MPS) requirements. Investors should watch for the board’s decision on the bonus ratio and record date, which will directly impact share liquidity and equity distribution.
Dharti Proteins to Evaluate Bonus Share Proposal for MPS Compliance
Meeting Date: October 13, 2026
Regulatory Driver: Rule 19A of SCRR (Minimum Public Shareholding)
Reader Takeaway: Bonus issue aimed at increasing public float; investors must watch for approved ratio and record date.
What just happened
Dharti Proteins Ltd has officially scheduled a Board of Directors meeting for October 13, 2026. The primary agenda includes two high-impact items: the approval of audited standalone financial results for the second quarter and the half-year ending September 30, 2026, and a crucial proposal for the issuance of bonus shares.
Why this matters
The proposal for bonus shares is not merely a capital restructuring exercise; it is a strategic move to ensure compliance with the Minimum Public Shareholding (MPS) requirements under Rule 19A of the Securities Contracts (Regulation) Rules, 1957. By increasing the number of shares in circulation, the company aims to meet SEBI's mandate regarding the public float, which is essential for maintaining listing eligibility and regulatory standing.
Financial Review
In addition to the bonus discussion, the board will review the company's financial performance for Q2 and the first half of FY27. Investors will receive the latest audited figures along with the interim audit report, providing a comprehensive view of the company's operational health as of September 30, 2026.
Risks to watch
While bonus issues are often viewed positively for liquidity, shareholders should remain cautious about the dilution of Earnings Per Share (EPS). The market will specifically look for the bonus ratio; a lower-than-expected ratio or failure to meet the MPS timeline could lead to uncertainty regarding regulatory compliance status.
What to track next
Following the October 13 meeting, the immediate priority for investors is the exchange disclosure regarding the specific bonus ratio and the designated record date. These details will determine the entitlement for existing shareholders and will set the stage for how the stock adjusts post-announcement.